China Medicine Announces Solid First Quarter 20... (mber 312007. Also as of March 31 2008 Ch...)

China Medicine Announces Solid First Quarter 2008 Results

Date:5/12/2008

mber 31, 2007. Also as of March 31, 2008, China Medicine had $5.2 million in cash and cash equivalents, a decrease of 11.2% from $5.7 million as of December 31, 2007. For the quarter ended March 31, 2008, cash used in operating activities was $1.1 million, compared with cash used in operating activities of $0.9 million for the quarter ended March 31, 2007. This increase in cash used in operations was primarily due to an increase in bank-guaranteed trade receivables of $1.7 million which resulted from our growth in sales. Stockholders' equity as of March 31, 2008 was $33.8 million, an increase of 3.7% over the $32.6 million recorded as of December 31, 2007.

2008 Outlook

"We believe our business is well positioned to take advantage of the industry growth as well as the increasing insurance coverage and government support in China," Mr. Yang commented. "Expenditures on pharmaceutical products in China are forecasted to grow 23.5% annually between 2007 and 2011 and reach $126.8 billion in 2011."

"As we enter into the second quarter, we remain focused on our near-term objectives of increasing our exclusive distribution rights and continuing our efforts to bulk up our proprietary product portfolio. We are also planning on identifying a pharmaceutical manufacturing acquisition target to become a more vertically integrated pharmaceutical company. We are confident that we have the right strategies for our Company. With a seasoned management team, we believe that we can continue to successfully execute our business plan going forward," concluded Mr. Yang.

Although China Medicine did not win any new exclusive distribution rights during the first quarter of 2008 due to the Chinese New Year holiday, the Company expects to make bids for, and succeed in obtaining, new exclusive distribution rights throughout Guangdong Province for a number of products before year end.

The Company is also on track to complete the documentation for laboratory trial
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related biology technology :

1. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
2. China-Biotics, Inc. Completes Foundation for Its New Plant
3. Amnis and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
4. Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
5. China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results
6. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
7. DuPont Partnering with China to Increase Farm Productivity
8. China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network
9. China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc.
10. Syngenta To Build Major Global Biotech Research Center in Beijing, China
11. American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance

Post Your Comments:

China Medicine Announces Solid First Quarter 20...(mber 312007. Also as of March 31 2008 Ch...)